Showing results (1991-2000 of 2,065) with videos related to
Sort By:
Pageof 207
NPJ Genomic Medicine|December 22, 2017
Erratum: Genomic landscape of high-grade meningiomasWenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, et al.Scientific Data|May 8, 2024
Getting your DUCs in a row - standardising the representation of Digital Use ConditionsFrancis Jeanson, Spencer J Gibson, Pinar Alper, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 10, 2019
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelinesJoanne M Bowen, Rachel J Gibson, Janet K Coller, et al.Cell Stem Cell|October 20, 2023
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulationChun-Wei Chen, Linda Zhang, Ravi Dutta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast CancerStefania Morganti, Christopher J Gibson, Qingchun Jin, et al.Plos Genetics|October 21, 2015
NINL and DZANK1 Co-function in Vesicle Transport and Are Essential for Photoreceptor Development in ZebrafishMargo Dona, Ruxandra Bachmann-Gagescu, Yves Texier, et al.Journal of Geriatric Oncology|September 26, 2022
'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancerRachel A Freedman, Tianyu Li, Mina S Sedrak, et al.Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.Pageof 207